A group of large international fund managers will today urge the pharmaceuticals industry to make public more information on drug research and create new business models offering better value for money.

A report commissioned by US, Dutch and British funds with $20bn invested in the healthcare sector says investors want greater insight into the quality of drugs under development and ways to assess productivity.